Hct116 Cells

Download PDF

Recent Publications on Hct116 Cells:
HDAC4 Promotes Growth of Colon Cancer Cells via Repression of p21. Monitoring Editor: John L. Cleveland The class II HDAC, HDAC4, is...	18th July, 2008	Department of Oncology, Albert Einstein Cancer Center, Montefiore Medical	Mol Biol Cell. 2008 Jul 16;. DOI Direct Link
CTCFL/BORIS is a methylation-independent DNA-binding protein that preferentially binds to the paternal H19 differentially methylated region. The CTCF paralog BORIS (brother of the regulator of imprinted sites) is an...	18th July, 2008	Radiation Oncology Branch, Center for Cancer Research, National Cancer	Cancer Res. 2008 Jul 15;68(14):5546-51. DOI Direct Link
Antibody Targeting of Camptothecin-Loaded PLGA Nanoparticles to Tumor Cells. Antibody targeting of drug substances can improve the efficacy of the...	17th July, 2008	School of Pharmacy, Queen's University Belfast, Medical Biology Centre, 97	Bioconjug Chem. 2008 Jul 16;. DOI Direct Link
Reactive oxygen species-mediated cyclin D1 degradation mediates tumor growth retardation in hypoxia, independently of p21(cip1) and hypoxia-inducible factor. Cell growth arrest is an adaptation process for tumor survival in hypoxic...	12th July, 2008	Department of Pharmacology, Seoul National University College of Medicine,	Cancer Sci. 2008 Jun 30;. DOI Direct Link
Stably transfected common fragile site sequences exhibit instability at ectopic sites. Common fragile sites (CFSs) are loci that are especially prone to forming...	11th July, 2008	Department of Human Genetics, University of Michigan, Ann Arbor, MI.	Genes Chromosomes Cancer. 2008 Jul 9;. DOI Direct Link
→View more research publications.

BioNews Results for Hct116 Cells:
Securin is required for chromosomal stability in human cells	PharmCast:  Apr 24 2008 12:13PM Matching: hct116 cells

Hct116 Cells Patents:
US Patent No.	Title
7148009	Cancer drug screen based on cell cycle uncoupling
7196068	Method for treating cancer using p38/JTV-1 and method for screening pharmaceutical composition for treating cancer
7205326	Aniline derivatives, their manufacture and use as pharmaceutical agents
7214480	Methods and compositions for diagnosing and suppressing metastasis thereof
7214660	Erythropoietin: remodeling and glycoconjugation of erythropoietin
→View more patents.

BioPortfolio Ltd. offers e-mail and postal lists for Hct116 Cells scientists - we have details of around 91 individuals working on Hct116 Cells .

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.